Stop TB Partnership

GDF Facts & Figures

145 countries have received deliveries worth $2.2 billion in TB medicines and diagnostics from GDF since its inception in 2001:

First-Line Medicines (since 2001)
  • Cumulative value of first-line medicines delivered: $784,928,135
  • Cumulative number of adult, first-line medicine treatments delivered: 33,951,014
  • Cumulative number of paediatric, first-line medicine treatments delivered: 2,576,354
  • Number of countries that have received first-line medicines via GDF: 128
Second-Line Medicines (since 2007)
  • Cumulative value of second-line medicines delivered: $1,063,485,093
  • Cumulative number of second-line medicine treatments delivered: TBD
  • Number of countries that have received second-line medicines via GDF: 129
Diagnostics (since 2008)
  • Cumulative value of diagnostics delivered: $327,856,717
  • Number of countries that have received diagnostics via GDF: 101

Last updated: March 2020

Please email us at gdf@stoptb.org for the most recent facts and figures.

ISO

GDF is ISO 9001:2015 compliant for the provision of quality assured anti-TB drugs and related services to eligible national TB control programmes.